PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 201 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2015. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $34,000 | -5.6% | 11,855 | +0.3% | 0.00% | – |
Q4 2021 | $36,000 | -66.7% | 11,820 | -23.1% | 0.00% | – |
Q3 2021 | $108,000 | -8.5% | 15,370 | +19.8% | 0.00% | – |
Q2 2021 | $118,000 | +11.3% | 12,825 | +18.3% | 0.00% | – |
Q1 2021 | $106,000 | -99.2% | 10,845 | -91.6% | 0.00% | -100.0% |
Q4 2017 | $12,796,000 | +52.9% | 129,447 | +85.2% | 0.01% | +66.7% |
Q3 2017 | $8,368,000 | +426.3% | 69,879 | +34.9% | 0.00% | +200.0% |
Q4 2016 | $1,590,000 | +411.3% | 51,803 | +1207.5% | 0.00% | – |
Q4 2015 | $311,000 | -24.3% | 3,962 | -27.4% | 0.00% | – |
Q3 2015 | $411,000 | -91.8% | 5,459 | -87.3% | 0.00% | -100.0% |
Q2 2015 | $5,034,000 | -80.6% | 43,121 | -60.8% | 0.00% | -80.0% |
Q1 2015 | $25,951,000 | +125.6% | 109,910 | +80.8% | 0.01% | +150.0% |
Q4 2014 | $11,503,000 | +72.4% | 60,778 | +117.3% | 0.00% | +33.3% |
Q3 2014 | $6,674,000 | +44.6% | 27,975 | -37.3% | 0.00% | +50.0% |
Q4 2013 | $4,616,000 | +167.7% | 44,589 | +38.7% | 0.00% | +100.0% |
Q3 2013 | $1,724,000 | – | 32,137 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 1,417,000 | $18,010,000 | 2.24% |
Palo Alto Investors LP | 1,405,680 | $17,866,000 | 0.87% |
PFM Health Sciences, LP | 2,838,376 | $36,076,000 | 0.68% |
TANG CAPITAL MANAGEMENT LLC | 349,400 | $4,441,000 | 0.60% |
Capital Impact Advisors, LLC | 127,029 | $1,615,000 | 0.59% |
Leap Investments LP | 29,100 | $370,000 | 0.50% |
Spark Investment Management LLC | 454,300 | $5,774,000 | 0.40% |
Partner Investment Management, L.P. | 27,567 | $350,000 | 0.37% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 262,945 | $3,342,000 | 0.26% |
Rock Springs Capital Management LP | 534,400 | $6,792,000 | 0.25% |